Avenue Therapeutics (ATXI) Stock Chart & Stock Price History $1.85 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.90 +0.04 (+2.43%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Avenue Therapeutics Stock Price Performance 5 Day Performance+5.71%1 Month Performance+4.52%3 Month Performance-7.50%6 Month Performance-46.38%Year-To-Date Performance-7.50%1 Year Performance-82.39% Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ATXI Stock Chart for Tuesday, January, 21, 2025 ATXI Chart by TradingView Avenue Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/21/2025$1.85$1.85$1.92$1.78220,584 shs$3.79 million01/20/2025$1.85$1.85$1.92$1.7943,222 shs$3.79 million01/17/2025$1.75$1.85+5.71%$1.92$1.7943,222 shs$3.79 million01/16/2025$1.90$1.75-7.89%$1.90$1.7269,234 shs$3.59 million01/15/2025$1.88$1.90+1.06%$1.94$1.8110,745 shs$3.90 million01/14/2025$1.90$1.88-1.05%$1.96$1.8231,778 shs$3.86 million01/13/2025$1.82$1.90+4.68%$2.04$1.66347,450 shs$3.90 million01/10/2025$1.86$1.82-2.42%$1.90$1.8115,826 shs$3.73 million01/09/2025$1.86$1.86$1.96$1.8038,914 shs$3.82 million01/08/2025$1.95$1.86-4.82%$1.96$1.8038,914 shs$3.82 million Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/07/2025$1.99$1.95-1.80%$2.13$1.9543,651 shs$4.01 million01/06/2025$2.06$1.99-3.40%$2.23$1.9947,546 shs$4.09 million01/03/2025$1.93$2.06+6.74%$2.14$1.9252,656 shs$4.23 million01/02/2025$2.00$1.93-3.50%$2.21$1.90182,662 shs$3.96 million01/01/2025$2.00$2.00$2.04$1.9127,091 shs$4.11 million12/31/2024$1.94$2.00+3.09%$2.04$1.9127,091 shs$4.11 million12/30/2024$1.94$1.94$1.96$1.8043,563 shs$3.99 million12/27/2024$1.86$1.94+4.30%$1.99$1.8432,429 shs$3.99 million12/26/2024$1.72$1.86+8.14%$1.89$1.7223,798 shs$3.82 million12/25/2024$1.72$1.72$1.80$1.7119,712 shs$3.53 million12/24/2024$1.80$1.72-4.44%$1.80$1.7119,712 shs$3.53 million12/23/2024$1.77$1.80+1.69%$1.85$1.6450,317 shs$3.70 million12/20/2024$1.80$1.77-1.67%$1.91$1.7629,664 shs$3.64 million Related Companies Minerva Neurosciences Stock Price Chart ProPhase Labs Stock Price Chart Cingulate Stock Price Chart Spruce Biosciences Stock Price Chart NeuroSense Therapeutics Stock Price Chart HCW Biologics Stock Price Chart Bright Green Stock Price Chart Flora Growth Stock Price Chart Imunon Stock Price Chart AIM ImmunoTech Stock Price Chart Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATXI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATXI Stock Alerts